Indonesia court ruling against pharma patent evergreening sets precedent

An Indonesian court ruled against a pharmaceutical company's patent evergreening practice, a first in the country. The decision, hailed by patient advocates, could influence other developing nations to challenge similar patent strategies. The ruling's broader impact on drug pricing and access remains to be seen.